Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone regeneration.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
Description
Kuros Biosciences is a life sciences company that discovers, develops, and delivers innovative biologic technologies focused on tissue repair and bone regeneration. The company's mission is to address unmet clinical needs for safer, faster, and more predictable bone healing. Its primary commercial product is MagnetOs, an advanced bone graft designed to enhance bone formation. The efficacy of MagnetOs is supported by a comprehensive global research program, "Project Fusion," which includes scientific, pre-clinical, and Level I human clinical studies. Kuros Biosciences serves surgeons and patients across multiple medical fields, including spine, extremities, trauma, and oncology, leveraging deep scientific expertise and collaboration with leading clinical experts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-16 02:00 |
Kuros Biosciences increases the annual guidance for 2025, The company reports 7…
|
English | 12.7 KB | ||
| 2025-09-18 02:00 |
Kuros statement on media inquiry concerning former Board member
|
English | 7.6 KB | ||
| 2025-09-04 02:00 |
Kuros Biosciences announces changes in the Board of Directors
|
English | 7.4 KB | ||
| 2025-08-14 02:00 |
Kuros Biosciences Reports First Half of 2025 Results
|
English | 22.7 KB | ||
| 2025-03-11 01:00 |
Kuros Biosciences grows sales to CHF 75.6 million for 2024
|
English | 19.2 KB | ||
| 2025-01-08 07:00 |
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | ||
| 2025-01-07 07:00 |
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 13.7 KB | ||
| 2025-01-07 01:00 |
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
|
English | 11.8 KB | ||
| 2024-11-19 07:00 |
Kuros Biosciences Expands into Extremities Markets
|
English | 18.5 KB | ||
| 2024-11-19 01:00 |
Kuros Biosciences Expands into Extremities Markets
|
English | 16.1 KB | ||
| 2024-10-10 02:00 |
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow brea…
|
English | 16.3 KB | ||
| 2024-08-08 07:00 |
Kuros Biosciences Reports First Half of 2024 Results
|
English | 37.6 KB | ||
| 2024-08-08 02:00 |
Kuros Biosciences Reports First Half of 2024 Results
|
English | 33.0 KB | ||
| 2024-06-25 07:00 |
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 17.2 KB | ||
| 2024-06-25 02:00 |
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
|
English | 14.9 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-22 | N/A | Executive member | Buy | None | 221,100.00 CHF |
| 2024-05-21 | N/A | Non-Executive member | Buy | None | 46,500.00 CHF |
| 2024-05-16 | N/A | Non-Executive member | Buy | None | 71,460.00 CHF |
| 2024-05-15 | N/A | Non-Executive member | Sell | None | 1,698,824.00 CHF |
| 2024-05-15 | N/A | Executive member | Sell | None | 3,120,216.00 CHF |
| 2024-05-07 | N/A | Non-Executive member | Buy | None | 48,750.00 CHF |
| 2024-04-29 | N/A | Executive member | Sell | None | 223.04 CHF |
| 2024-04-26 | N/A | Executive member | Sell | None | 19,296.00 CHF |
| 2024-04-25 | N/A | Executive member | Sell | None | 30,645.00 CHF |
| 2023-11-29 | N/A | Executive member | Sell | None | 9,270.00 CHF |
Peer Companies
